Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gicquel

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 12, 2019
Therapeutic Applications of Ethanol: A ReviewBrendan Le Daré, Thomas Gicquel
Drug Metabolism Reviews|October 25, 2019
Ethanol and its metabolites: update on toxicity, benefits, and focus on immunomodulatory effectsBrendan Le Daré, Vincent Lagente, Thomas Gicquel
International Journal of Molecular Sciences|March 6, 2021
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Presse Medicale (Paris, France : 1983)|February 17, 2016
[The NLRP3 inflammasome: Physiopathology and therapeutic application]Thomas Gicquel, Sacha Robert, Tatiana Victoni, et al.
Toxins|July 2, 2021
Toxic Effects of Amanitins: Repurposing Toxicities toward New TherapeuticsBrendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Medecine Sciences : M/S|March 19, 2021
[Once upon a time the hepatotoxicity…]Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Drug Testing and Analysis|November 24, 2018
Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequatSophie Allard, Pierre-Marie Allard, Isabelle Morel, et al.
Fundamental & Clinical Pharmacology|November 26, 2016
Purinergic receptors: new targets for the treatment of gout and fibrosisThomas Gicquel, Brendan Le Daré, Elisabeth Boichot, et al.
Presse Medicale (Paris, France : 1983)|March 1, 2016
[Xenon: From rare gaz to doping product]Camille Tassel, Brendan Le Daré, Isabelle Morel, et al.
Plos One|April 6, 2016
Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate CellsSacha Robert, Thomas Gicquel, Aude Bodin, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 12, 2019
Therapeutic Applications of Ethanol: A ReviewBrendan Le Daré, Thomas Gicquel
Drug Metabolism Reviews|October 25, 2019
Ethanol and its metabolites: update on toxicity, benefits, and focus on immunomodulatory effectsBrendan Le Daré, Vincent Lagente, Thomas Gicquel
International Journal of Molecular Sciences|March 6, 2021
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Presse Medicale (Paris, France : 1983)|February 17, 2016
[The NLRP3 inflammasome: Physiopathology and therapeutic application]Thomas Gicquel, Sacha Robert, Tatiana Victoni, et al.
Toxins|July 2, 2021
Toxic Effects of Amanitins: Repurposing Toxicities toward New TherapeuticsBrendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Medecine Sciences : M/S|March 19, 2021
[Once upon a time the hepatotoxicity…]Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Drug Testing and Analysis|November 24, 2018
Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequatSophie Allard, Pierre-Marie Allard, Isabelle Morel, et al.
Fundamental & Clinical Pharmacology|November 26, 2016
Purinergic receptors: new targets for the treatment of gout and fibrosisThomas Gicquel, Brendan Le Daré, Elisabeth Boichot, et al.
Presse Medicale (Paris, France : 1983)|March 1, 2016
[Xenon: From rare gaz to doping product]Camille Tassel, Brendan Le Daré, Isabelle Morel, et al.
Plos One|April 6, 2016
Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate CellsSacha Robert, Thomas Gicquel, Aude Bodin, et al.
Pageof 8